MitoTam bromide, hydrobromide Catalog No.:M17827-C Smiles: CCC(C)(C)C(=O)C(=O)N1CCCC[C@H]1C(=O)O[C@H](CCC1=CC(OC)=C(C=C1)OC)C1=CC(=CC=C1)NC(=O)CCC(O)=O

Smiles: CCC(C)(C)C(=O)C(=O)N1CCCC[C@H]1C(=O)O[C@H](CCC1=CC(OC)=C(C=C1)OC)C1=CC(=CC=C1)NC(=O)CCC(O)=O

PubMed PMID: 26136480

in which Src family kinases and CDKs are activated

Smiles: CN(C1C=CC(=CC=1)OC(=O)C1=CC=CO1)C(=O)C(Cl)Cl

Pétigny-Lechartier C

MitoTam bromide, hydrobromide Catalog No.:M17827-C Smiles: CCC(C)(C)C(=O)C(=O)N1CCCC[C@H]1C(=O)O[C@H](CCC1=CC(OC)=C(C=C1)OC)C1=CC(=CC=C1)NC(=O)CCC(O)=OMitoTam bromide, hydrobromide, a Tamoxifen derivative, is an electron transport chain (ETC) inhibitor. MitoTam bromide, hydrobromide reduces mitochondrial membrane potential in senescent cells and affects mitochondrial morphology. MitoTam bromide, hydrobromide is an effective anticancer agent, suppresses respiratory complexes (CI respiration) and disrupts respiratory supercomplexes (SCs) formation in breast cancer cells. Product information CAS